Literature DB >> 15331847

Are multilateral malaria research and control programs the most successful? Lessons from the past 100 years in Africa.

Martin S Alilio1, Ib C Bygbjerg, Joel G Breman.   

Abstract

Multilateral malaria research and control programs in Africa have regained prominence recently as bilateral assistance has diminished. The transnational nature of the threat and the need for inspired leadership, good coordination, and new discoveries to decrease the impact of the disease has led to the founding of the Multilateral Initiative on Malaria, the Roll Back Malaria Project, Global Fund for HIV, Tuberculosis and Malaria (Global Fund), the Medicines for Malaria Venture, and the Malaria Vaccine Initiative, among other groups. Historically, the most striking feature of malaria control and elimination activities was the connectedness and balance between malaria research and control especially, from 1892 to 1949. A combination of scientific originality, perseverance in research, integrated approaches, and social concern were the keys for success. The elimination of Anopheles gambiae from Upper Egypt in 1942 using integrated vector control methods is a prime example of malaria control during the first half of the 20th century where those factors were brought together. After 1949, there were three decades of great optimism. Four notable landmarks characterized this period: the Kampala Conference in 1950; the Global Malaria Eradication Program beginning in 1955; the primary health care strategies adopted by most African States after attaining their political independence in the 1960s, and accelerating in the 1980s; and creation of the Special Program in Training and Research in Tropical Diseases at the World Health Organization in 1975. The initial highly encouraging operational results, largely obtained in temperate or subtropical areas where transmission was unstable, engendered undue expectations for the success of identical antimalarial measures elsewhere. Many were convinced that the eradication was in sight, such that support for malaria research virtually ceased. Young, bright scientists were discouraged from seeking a career in a discipline that appeared to soon become superfluous. It took more than three decades to modify antimalarial strategies and to rehabilitate long-term control as an intermediate objective. In Africa, although multilateral malaria programs have grown over the past half century and proved the most successful, fragmentation of co-ordination remains and is a major challenge. The proliferation of malaria programs in the late 1990s has brought substantial additional funds and expertise. However, excessive funding competition and failure of different programs to collaborate has resulted in poor communication and duplication of activities. The capacities of the African nations to conduct high-quality research and to coordinate control efforts are in great jeopardy. There is an urgent need for a non-partisan umbrella organ to coordinate and facilitate the network of alliances and programs in malaria research and control in Africa. Copyright 2004 The American Society of Tropical Medicine and Hygiene

Entities:  

Mesh:

Year:  2004        PMID: 15331847

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Uncertainty in mapping malaria epidemiology: implications for control.

Authors:  David Sullivan
Journal:  Epidemiol Rev       Date:  2010-06-25       Impact factor: 6.222

Review 2.  Malaria in India: challenges and opportunities.

Authors:  A P Dash; Neena Valecha; A R Anvikar; A Kumar
Journal:  J Biosci       Date:  2008-11       Impact factor: 1.826

Review 3.  A research agenda for malaria eradication: health systems and operational research.

Authors: 
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

4.  Policy development in malaria vector management in Mozambique, South Africa and Zimbabwe.

Authors:  Julie Cliff; Simon Lewin; Godfrey Woelk; Benedita Fernandes; Alda Mariano; Esperança Sevene; Karen Daniels; Sheillah Matinhure; Andrew Oxman; John Lavis
Journal:  Health Policy Plan       Date:  2010-02-21       Impact factor: 3.344

Review 5.  A research agenda to underpin malaria eradication.

Authors:  Pedro L Alonso; Graham Brown; Myriam Arevalo-Herrera; Fred Binka; Chetan Chitnis; Frank Collins; Ogobara K Doumbo; Brian Greenwood; B Fenton Hall; Myron M Levine; Kamini Mendis; Robert D Newman; Christopher V Plowe; Mario Henry Rodríguez; Robert Sinden; Laurence Slutsker; Marcel Tanner
Journal:  PLoS Med       Date:  2011-01-25       Impact factor: 11.069

6.  Antimalarial Effects of Iranian Flora Artemisia sieberi on Plasmodium berghei In Vivo in Mice and Phytochemistry Analysis of Its Herbal Extracts.

Authors:  Hossein Nahrevanian; Bayram Sheykhkanlooye Milan; Masoud Kazemi; Reza Hajhosseini; Soudeh Soleymani Mashhadi; Shahab Nahrevanian
Journal:  Malar Res Treat       Date:  2012-01-23

7.  In Vivo Antimalarial Effects of Iranian Flora Artemisia khorassanica against Plasmodium berghei and Pharmacochemistry of its Natural Components.

Authors:  H Nahrevanian; B Esmaeili; M Kazemi; H Nazem; M Amini
Journal:  Iran J Parasitol       Date:  2010-03       Impact factor: 1.012

Review 8.  The global health system: linking knowledge with action--learning from malaria.

Authors:  Gerald T Keusch; Wen L Kilama; Suerie Moon; Nicole A Szlezák; Catherine M Michaud
Journal:  PLoS Med       Date:  2010-01-19       Impact factor: 11.069

Review 9.  Diversity and transmission competence in lymphatic filariasis vectors in West Africa, and the implications for accelerated elimination of Anopheles-transmitted filariasis.

Authors:  Dziedzom K de Souza; Benjamin Koudou; Louise A Kelly-Hope; Michael D Wilson; Moses J Bockarie; Daniel A Boakye
Journal:  Parasit Vectors       Date:  2012-11-14       Impact factor: 3.876

10.  Imperfect duplicate insertions type of mutations in plasmepsin V modulates binding properties of PEXEL motifs of export proteins in Indian Plasmodium vivax.

Authors:  Manmeet Rawat; Sonam Vijay; Yash Gupta; Pramod Kumar Tiwari; Arun Sharma
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.